HPV Prevalence in the Mouth and Oropharynx of the Tonsillectomy Population

University of Birmingham937 enrolled

Overview

The principal aim of this study is to provide vital current data on the prevalence, distribution and natural history of Human Papilloma Virus (HPV) infection in the mouth. This data is an essential requirement for the assessment, development and evaluation of cost effectiveness of prophylactic vaccination and screening programmes.

Patients undergoing a tonsillectomy operation for non-cancerous reasons will be recruited for this study. They will be asked to complete two questionnaires (study and sexual practices), provide saliva, urine and a blood sample. Following anaesthesia, oropharyngeal brushings and a tonsillectomy will be performed and all the samples will be processed for evidence of HPV infection.

Study Type

OBSERVATIONAL

Enrollment

937

Conditions

Chronic Tonsillitis

Eligibility

Sex: ALLMax age: 65 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. Subjects undergoing tonsillectomy for non cancer reasons including operations for: recurrent tonsillitis, asymmetric tonsils, snoring surgery or obstructive sleep apnoea 2. Age - 0 to 65 years 3. Subject or legal guardian has given informed written consent Exclusion Criteria: 1. Subjects undergoing adenoidectomy alone with no tonsillectomy 2. Subjects with previous oropharyngeal cancer or oral cancer, or any other head and neck cancer such as nasopharyngeal or laryngeal cancer that is currently undergoing or has previously been diagnosed or treated 3. Learning disability preventing an adult over 16 years old from giving their own consent

Locations (8)

University Hospitals Coventry & Warwickshire Trust

Coventry, England, United Kingdom

University Hospital Birmingham

Birmingham, West Midlands, United Kingdom

Birmingham City Hospital

Birmingham, United Kingdom

Birmingham Children Hospital

Birmingham, United Kingdom

Outcomes

Primary Outcomes

Occurrence of HPV in tonsils and in oral scrape sample

Presence of HPV result

Time frame: 36 months

Secondary Outcomes

HPV vaccination status

vaccination received yes/no and the type of vaccination description

Time frame: 36 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.